Clinical Trials
2 trialsNCT04636632 2022-11-07
Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 1 Completed
NCT01649258 2017-11-17
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
University of Southern California
Phase 1 Terminated